3,6,9,12-Tetraoxa-15-azanonadecan-1-ol (5732-46-7)
Identification |
Properties |
Safety Data |
|
|
Other Product
- 3,6,9,12-Tetraoxa-15-azanonadecan-19-oic acid, 1-hydroxy-13-methyl-16-oxo-17-sulfo-, 15-coco alkyl derivs., disodium salts
- 15-ethyl-3,6,9,12-tetraoxa-15-azaheptadecan-1-ol
- 4,7,10,13-Tetraoxa-3-silapentadecan-15-ol, 2,2-dimethyl-3,3-diphenyl-
- 4,7,10,13-Tetraoxa-3-silapentadecan-15-ol, 2,2,3,3-tetramethyl-
- 1/C15H11Br/c16-10-15-13-7-3-1-5-11(13)9-12-6-2-4-8-14(12)15/h1-9H,10H
- 1/C10H7N5/c1-15-6-7(5-11)9-4-8(13-14-12)2-3-10(9)15/h2-4,6H,1H
- 1/C15H18O3/c1-8-4-5-13(16)15(3)7-12-10(6-11(8)15)9(2)14(17)18-12/h7,11,13,16H,1,4-6H2,2-3H3/t11-,13+,15+/m0/s
- 1/C14H12NS/c1-2-6-12(7-3-1)10-15-11-16-14-9-5-4-8-13(14)15/h1-9,11H,10H2/q+
- 1/C15H10O4/c16-11-7-3-1-5-9(11)15-14(18)13(17)10-6-2-4-8-12(10)19-15/h1-8,16,18
- 1/C12H24O2Te/c1-14-12(13)10-8-6-4-3-5-7-9-11-15-2/h3-11H2,1-2H
- 1/C12H17NO2/c14-11-4-2-1-3-9(11)7-10-8-12(5-6-12)15-13-10/h9H,1-8H
- 1/C14H19NO2/c1-3-12-10-17-9-8-15(12)14-7-5-4-6-13(14)11(2)16/h4-7,12H,3,8-10H2,1-2H
- 1/C15H18O2/c1-11(16)6-7-12-4-3-5-13-10-14(17-2)8-9-15(12)13/h4,8-10H,3,5-7H2,1-2H
- 1/C14H16O4/c1-5-10-12-9(14(15)18-10)6-7-11(16-4)13(12)17-8(2)3/h5-8,10H,1H2,2-4H
- 1/C11H14N2O6/c1-17-7(14)4-12-2-3-13-9(10(12)15)8-6(19-13)5-18-11(8)16/h6,8-9H,2-5H2,1H
- 1/C17H16N2O3/c1-9(20)12-8-14-15-11(6-7-19(14)17(22)16(12)21)10-4-2-3-5-13(10)18-15/h2-5,8-9,18,20-21H,6-7H2,1H
- 1/C18H19NO4/c1-22-15-8-11-10(7-13(15)20)5-12-16-9(3-4-19-12)6-14(21)18(23-2)17(11)16/h6-8,12,19-21H,3-5H2,1-2H
- 1/C19H15ClN2O2S/c1-11-19(23)24-17-18(25-11)22(2)15-9-8-13(20)10-14(15)16(21-17)12-6-4-3-5-7-12/h3-11H,1-2H
- 1/C15H18N2O/c18-15-12-7-3-2-6-11(12)14-16-13-8-4-1-5-10(13)9-17(14)15/h2-3,6-7,10,13-14,16H,1,4-5,8-9H2/t10-,13-,14-/m1/s
- 1/C11H18O4/c1-14-10(12)8-5-3-4-6-9(7-8)11(13)15-2/h8-9H,3-7H2,1-2H3/t8-,9